OPKO Health, Inc. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
OPKO Health, Inc. (OPK) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 0 shares for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2024-11-07
- OPKO Health, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2024-09-30 was 0.00 shares.
- OPKO Health, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2023-09-30 was 0.00 shares.
- OPKO Health, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2017-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- OPKO Health, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2016-09-30 was 0.00 shares, a 100.00% decline year-over-year.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month |
|---|---|---|---|
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-07 | 0.00 shares 10-Q · filed 2024-11-07 | |
| 2023-09-30 | 0.00 shares 10-Q · filed 2024-11-07 | 0.00 shares 10-Q · filed 2024-11-07 | |
| 2017-06-30 | 0.00 shares 10-Q · filed 2017-08-08 | 0.00 shares 10-Q · filed 2017-08-08 | |
| 2016-09-30 | 0.00 shares 10-Q · filed 2016-11-07 | 0.00 shares 10-Q · filed 2016-11-07 | |
| 2016-06-30 | 661.00K shares 10-Q · filed 2017-08-08 | 1.27M shares 10-Q · filed 2017-08-08 | |
| 2015-09-30 | 2.06M shares 10-Q · filed 2016-11-07 | 0.00 shares 10-Q · filed 2016-11-07 | |
| 2015-06-30 | 0.00 shares 10-Q · filed 2016-08-08 | 0.00 shares 10-Q · filed 2016-08-08 | |
| 2014-09-30 | 0.00 shares 10-Q · filed 2015-11-09 | 0.00 shares 10-Q · filed 2015-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |